Home|Journals|Articles by Year Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access

Review Article

JCR. 2019; 6(6): 1-6

Multi Drug Resistance in Cancer Therapy-An Overview


Multidrug resistance is a mechanism by which chemotherapeutic drugs develops resistance in cancer treatment. Multidrug resistance (MDR) is the
most essential test to compelling chemotherapeutic efficacy against tumor growth. Improvements in the DNA microarray, proteomics innovation
and the outgrowth of focused treatments convey the new ways to deal with the drug resistance in spite the structures of the new chemotherapy
drugs. The chemotherapeutic drugs develops multi drug resistance as the drug treats the tumor but the cells tends to shows a resistant effect for the
same drug when used again, despite their diverse concoction structure and distinctive mechanism of intracellular activity. The scope of the review
explains us about multi drug resistance, the mechanisms of malignant growth inhibiting drugs and overcoming multidrug-resistance.

Search Criteria: A literature survey was done in Scopus, PubMed, Google Scholar, and Science Direct database for articles for published articles
from 1946 to 2019 on multidrug resistant and its mechanism on cancer

Key words: Multidrug resistance, Cancer, Chemotherapy, Chemo sensitizer

Full-text options

Full-text Article

Oxidants and Antioxidants in Medical Science


BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.